Results 61 to 70 of about 29,902 (249)

The role of ultrasound and lymphoscintigraphy in the assessment of axillary lymph nodes in patients with breast cancer

Journal of Ultrasonography, 2016
Breast cancer is the most common malignancy and the leading cause of death due to cancer in European women. Mammography screening programs aimed to increase the detection of early cancer stages were implemented in numerous European countries.
Michał Nieciecki, Katarzyna Dobruch-Sobczak, Paweł Wareluk, Anna Gumińska, Ewa Białek, Marek Cacko, Leszek Królicki   +6 more
doaj   +1 more source

Sentinel Lymph Node Biopsy in Eyelid Malignancy - A Brief Update

Delhi Journal of Ophthalmology, 2020
Sentinel lymph node biopsy detects metastasis in the initial stages before the regional spread becomes clinically detectable and aids in the staging of the tumor.
Neelam Pushker, Gautam Lokdarshi
doaj   +1 more source

Activatable smart contrast agents for photoacoustic imaging

Smart Molecules, EarlyView.
This review highlights recent advances in smart activatable photoacoustic imaging (PAI) contrast agents, which dynamically modulate their optical properties in response to external stimuli or microenvironmental cues. It discusses their molecular design, activation mechanisms, biomedical applications, and future prospects for clinically tailored use ...
Donghyeon Oh, Jihye Lee, Suyoung Park, Juyoung Yoon, Won Jong Kim, Chulhong Kim   +5 more
wiley   +1 more source

Sentinel lymph node biopsy in periocular merkel cell carcinoma: a case report

BMC Research Notes, 2017
Background The National Comprehensive Cancer Network guidelines for Merkel cell carcinoma recommend performance of the sentinel lymph node biopsy in all patients with clinically negative nodal disease for staging and treatment.
Dan C. Filitis, Gyorgy Paragh, Faramarz H. Samie, Nathalie C. Zeitouni   +3 more
doaj   +1 more source

Recurrence Patterns and Prognostic Factors in Sentinel Lymph Node‐Negative Melanoma in a Taiwanese Cohort With Predominant Acral Melanoma

The Journal of Dermatology, EarlyView.
ABSTRACT Cutaneous melanoma in Asian populations is characterized by a predominance of acral melanoma and distinct clinicopathologic features. Although sentinel lymph node biopsy (SLNB) is widely used for staging, a subset of SLN‐negative patients still develop recurrence, and evidence regarding recurrence patterns and prognostic factors in this group ...
Chih‐Yuan Chang, Cheng‐Yuan Li, Tien‐Hsiang Wang, Chi‐Han Tsai, Jai‐Sing Yang, Yu‐Jen Chiu   +5 more
wiley   +1 more source

Outcomes for Patients With Micro‐Invasive or Small HER2+ Breast Cancer in Northern Sydney Local Health District

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This retrospective study of patients with small, node‐negative HER2+ breast cancer found favorable 5‐year invasive disease‐free survival rates—93% for pT1mic/a disease and 100% for pT1b disease. Trastuzumab was administered to 66% of patients and was associated with larger tumor size and higher histologic grade.
Yuanyuan Xue, Katrina Moore, Tricia Saurine, David Chan, Lina Pugliano, Connie Diakos   +5 more
wiley   +1 more source

Sentinel-Lymph-Node Biopsy [PDF]

New England Journal of Medicine, 1999
O, Schillaci, F, Scopinaro
  +6 more sources

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)

BMC Cancer, 2017
Background Studies showed that axillary lymph node dissection can be safely omitted in presence of positive sentinel lymph node(s) in breast cancer patients treated with breast conserving therapy.
L. M. van Roozendaal, M. L. G. Vane, T. van Dalen, J. A. van der Hage, L. J. A. Strobbe, L. J. Boersma, S. C. Linn, M. B. I. Lobbes, P. M. P. Poortmans, V. C. G. Tjan-Heijnen, K. K. B. T. Van de Vijver, J. de Vries, A. H. Westenberg, A. G. H. Kessels, J. H. W. de Wilt, M. L. Smidt   +15 more
doaj   +1 more source

Breast Angiosarcoma: 15‐Years Experience

ANZ Journal of Surgery, EarlyView.
ABSTRACT Background Breast angiosarcoma is a rare, aggressive malignancy that can be primary (PAS) or secondary (SAS). This study evaluates the management and outcomes of breast angiosarcoma in a single‐center breast/surgical oncology unit. Methods A retrospective review was conducted on patients with histologically confirmed PAS or SAS who underwent ...
Gaik Si Quah, Christopher Pyke, Christopher Allan   +2 more
wiley   +1 more source